CSIMarket
 
Nanobiotix S a   (NASDAQ: NBTX)
 

Nanobiotix S A's Suppliers Performance

NBTX's Supply Chain




 
NBTX Costs vs Sales of Suppliers Growth

• More on NBTX Suppliers






Nanobiotix S A's Comment on Supply Chain


The company collaborates with contract manufacturing organizations that comply with international professional standards, including Good Manufacturing Practices (GMP) guidelines established by the International Council for Harmonization. In November 2017, the company opened a manufacturing facility in Villejuif BioPark near Paris, France, to increase production capacity for JNJ-1900 (NBTXR3) intended for clinical trials. In 2024, Janssen Pharmaceutica NV began replicating the company's manufacturing processes under an exclusive license agreement, enabling Johnson & Johnson to produce JNJ-1900 (NBTXR3) to support clinical development and potential future commercial manufacturing. Production activities at the company's own facilities continue concurrently. In 2025, Chemistry, Manufacturing, and Controls (CMC) activities for the Curadigm platform were initiated to support both internal and external collaborations.

Nanobiotix S A's Comment on Supply Chain


The company collaborates with contract manufacturing organizations that comply with international professional standards, including Good Manufacturing Practices (GMP) guidelines established by the International Council for Harmonization. In November 2017, the company opened a manufacturing facility in Villejuif BioPark near Paris, France, to increase production capacity for JNJ-1900 (NBTXR3) intended for clinical trials. In 2024, Janssen Pharmaceutica NV began replicating the company's manufacturing processes under an exclusive license agreement, enabling Johnson & Johnson to produce JNJ-1900 (NBTXR3) to support clinical development and potential future commercial manufacturing. Production activities at the company's own facilities continue concurrently. In 2025, Chemistry, Manufacturing, and Controls (CMC) activities for the Curadigm platform were initiated to support both internal and external collaborations.







NBTX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Nanobiotix S a 1,600.04 36.50 -26.84 97
SUBTOTAL 0.00 0.00 0.00 -


Sources: Nanobiotix S a 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Nanobiotix S a ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.